中國軟件(600536.SH):中軟系統擬向原股東增資擴股
格隆匯 2 月 8日丨中國軟件(600536.SH)公佈,公司子公司中軟信息系統工程有限公司(“中軟系統”)擬以1.6元/元註冊資本的價格面向原股東增資擴股,新增註冊資本9191.1764萬元,其中公司以9602.5111萬元認購新增註冊資本6001.5694萬元,中軟萬維以103.3712萬元認購新增註冊資本64.6070萬元,中電有限以5000萬元認購新增註冊資本3125萬元。
增資完成後,中軟系統註冊資本增至31691.1764萬元,公司、中軟萬維、中電有限持股比例不變,仍然分別為65.3%、0.7%、34%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.